CHAMPIONS ONCOLOGY INC (CSBR) Stock Analyst Earnings Estimates
NASDAQ:CSBR - Nasdaq - US15870P3073 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 53.87M 9.69% | 50.155M -6.90% | 56.944M 13.54% | 62.238M 9.30% | 81.638M 31.17% | 95.925M 17.50% | 113.19M 18.00% | 133.57M 18.01% | |
| EBITDA YoY % growth | -2.2M -198.21% | -5.054M -129.73% | 6.486M 228.33% | 4.952M -23.65% | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -4.45M -829.51% | -6.921M -55.53% | 4.846M 170.02% | 1.946M -59.84% | 6.123M 214.65% | 9.592M 56.66% | 14.148M 47.50% | 18.032M 27.45% | |
| Operating Margin | -8.26% | -13.80% | 8.51% | 3.13% | 7.50% | 10.00% | 12.50% | 13.50% | |
| EPS YoY % growth | -0.39 -1,400.00% | -0.49 -25.64% | 0.45 191.84% | 0.22 -50.13% | N/A | N/A | N/A | N/A |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.01 -109.27% | 0.01 -79.60% | 0.12 -66.00% | 0.08 216.57% |
| Revenue Q2Q % growth | 13.783M -1.98% | 14.323M 6.18% | 17.866M 4.85% | 17.387M 40.73% |
| EBITDA Q2Q % growth | -102K -105.74% | 94.86K -94.00% | 2.173M -62.18% | 1.518M 2,151.35% |
| EBIT Q2Q % growth | 916.98K -31.00% | 735.42K 0.47% | 1.41M -68.66% | 728.28K 142.49% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2025 Q2Q % growth | -0.07 -800.00% | -0.20 | 0.13 | 65.69% |
| Q3 2025 Q2Q % growth | 0.36 325.00% | -0.01 | 0.37 | 3,629.41% |
| Q2 2025 Q2Q % growth | 0.05 133.33% | 0.01 | 0.04 | 390.20% |
| Q1 2025 Q2Q % growth | 0.11 157.89% | -0.03 | 0.14 | 459.48% |
| Q4 2024 Q2Q % growth | 0.01 105.26% | -0.16 | 0.17 | 106.13% |
| Q3 2024 Q2Q % growth | -0.16 11.11% | -0.06 | -0.10 | -161.44% |
| Q2 2024 Q2Q % growth | -0.15 | -0.17 | 0.02 | 13.49% |
| Q1 2024 Q2Q % growth | -0.19 -850.00% | -0.12 | -0.07 | -61.98% |
| Q4 2023 Q2Q % growth | -0.19 -533.33% | -0.13 | -0.06 | -49.02% |
| Q3 2023 Q2Q % growth | -0.18 -460.00% | -0.04 | -0.14 | -404.20% |
| Q2 2023 Q2Q % growth | 0.00 -100.00% | -0.01 | 0.01 | 100.00% |
| Q1 2023 Q2Q % growth | -0.02 -100.00% | 0.01 | -0.03 | -296.08% |
| Q4 2022 Q2Q % growth | -0.03 25.00% | 0.03 | -0.06 | -217.65% |
| Q3 2022 Q2Q % growth | 0.05 | 0.03 | 0.02 | 96.08% |
| Q2 2022 Q2Q % growth | 0.02 | 0.01 | 0.01 | 292.16% |
| Q1 2022 Q2Q % growth | -0.01 -200.00% | 0.01 | -0.02 | -198.04% |
| Q4 2021 Q2Q % growth | -0.04 71.43% | 0.00 | -0.04 | % |
| Q3 2021 Q2Q % growth | 0.05 66.67% | 0.01 | 0.04 | 634.93% |
| Q2 2021 Q2Q % growth | 0.00 -100.00% | 0.00 | 0.00 | % |
| Q1 2021 Q2Q % growth | 0.01 120.00% | 0.02 | -0.01 | -50.98% |
| Q4 2020 Q2Q % growth | -0.14 -1,300.00% | 0.02 | -0.16 | -1,015.03% |
| Q3 2020 Q2Q % growth | 0.03 | 0.03 | 0.00 | 10.28% |
| Q2 2020 Q2Q % growth | 0.02 -33.33% | 0.01 | 0.01 | 161.44% |
| Q1 2020 Q2Q % growth | -0.05 -200.00% | 0.04 | -0.09 | -222.55% |
| Q4 2019 Q2Q % growth | -0.01 | 0.03 | -0.04 | -132.68% |
| Q3 2019 Q2Q % growth | 0.00 | 0.03 | -0.03 | -100.00% |
| Q2 2019 Q2Q % growth | 0.03 | 0.04 | -0.01 | -26.47% |
| Q1 2019 Q2Q % growth | 0.05 | 0.01 | 0.04 | 390.20% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2025 Q2Q % growth | 12.355M -11.76% | 12.253M | 102K | 0.83% |
| Q3 2025 Q2Q % growth | 17.039M 41.77% | 13.191M | 3.848M | 29.17% |
| Q2 2025 Q2Q % growth | 13.489M 16.56% | 13.315M | 174K | 1.31% |
| Q1 2025 Q2Q % growth | 14.061M 11.94% | 13.492M | 569K | 4.22% |
| Q4 2024 Q2Q % growth | 14.002M 7.12% | 12.946M | 1.056M | 8.16% |
| Q3 2024 Q2Q % growth | 12.019M -5.88% | 13.746M | -1.727M | -12.56% |
| Q2 2024 Q2Q % growth | 11.573M -18.96% | 13.101M | -1.528M | -11.66% |
| Q1 2024 Q2Q % growth | 12.561M -8.65% | 13.326M | -765K | -5.74% |
| Q4 2023 Q2Q % growth | 13.071M 1.48% | 13.117M | -46K | -0.35% |
| Q3 2023 Q2Q % growth | 12.77M -3.18% | 13.396M | -626K | -4.67% |
| Q2 2023 Q2Q % growth | 14.28M 21.12% | 14.065M | 215K | 1.53% |
| Q1 2023 Q2Q % growth | 13.75M 22.22% | 13.457M | 293K | 2.18% |
| Q4 2022 Q2Q % growth | 12.88M 21.97% | 12.978M | -98K | -0.76% |
| Q3 2022 Q2Q % growth | 13.19M 22.02% | 12.718M | 472K | 3.71% |
| Q2 2022 Q2Q % growth | 11.79M 16.50% | 11.78M | 10K | 0.08% |
| Q1 2022 Q2Q % growth | 11.25M 17.80% | 11.195M | 55K | 0.49% |
| Q4 2021 Q2Q % growth | 10.56M 20.69% | 10.231M | 329K | 3.22% |
| Q3 2021 Q2Q % growth | 10.81M 19.98% | 10.346M | 464K | 4.48% |
| Q2 2021 Q2Q % growth | 10.12M 32.63% | 9.573M | 547K | 5.71% |
| Q1 2021 Q2Q % growth | 9.55M 41.69% | 8.882M | 668K | 7.52% |
| Q4 2020 Q2Q % growth | 8.75M 13.34% | 8.454M | 296K | 3.50% |
| Q3 2020 Q2Q % growth | 9.01M 40.12% | 8.289M | 721K | 8.70% |
| Q2 2020 Q2Q % growth | 7.63M 14.05% | 7.513M | 117K | 1.56% |
| Q1 2020 Q2Q % growth | 6.74M 8.19% | 7.65M | -910K | -11.90% |
| Q4 2019 Q2Q % growth | 7.72M | 6.503M | 1.217M | 18.71% |
| Q3 2019 Q2Q % growth | 6.43M | 6.73M | -300K | -4.46% |
| Q2 2019 Q2Q % growth | 6.69M | 6.445M | 245K | 3.80% |
| Q1 2019 Q2Q % growth | 6.23M | 5.754M | 476K | 8.27% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -116.67% | -116.67% | 0% | 0% |
| Revenue | -7.86% | -7.86% | 0% | 0% |